China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective clinical study of individualized chemotherapy regimens for malignant ovarian germ cell tumors based on risk stratification'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133929
Registration Time: 2026/10/09
Type: Observational study
Primary Sponsor: Peking Union Medical College Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=346431
Published by HT Digital Content Services with permission from Health Daily Digest....